COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
ARGAN: S&P MAINTAINED THE “INVESTMENT GRADE” STATUS WITH A “BBB-” RATING AND A “STABLE” OUTLOOK
S&P Global Ratings maintains ARGAN's 'BBB-' rating with a 'Stable' outlook despite CARAT portfolio withdrawal. Company targets LTV ratio of 41.5% and net debt to EBITDA ratio of 8.7 times for 2025 -
-
-
COMMUNIQUÉ DE PRESSE
Coinsilium Group Limited: UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2025
Coinsilium Group Limited announces unaudited consolidated interim financial statements for the six-month period ended 30 June 2025, showing growth in Bitcoin holdings and strategic investments in digital assets -
COMMUNIQUÉ DE PRESSE
fox e-mobility AG: Preliminary agreement with Akkodis Germany. Proprietary new engineering team
fox e-mobility AG signs preliminary agreement with Akkodis Germany for the development and production of MIA 2.0 drivable prototype, introducing new engineering team and key appointments -
-
COMMUNIQUÉ DE PRESSE
EXAIL TECHNOLOGIES S.A. ANNONCE LE SUCCES DE SON OFFRE D'OBLIGATIONS À DURÉE INDETERMINÉE À OPTION DE REMBOURSEMENT EN NUMÉRAIRE ET/OU EN ACTIONS NOUVELLES ET/OU EXISTANTES (ODIRNANE) POUR UN MONTANT NOMINAL DE 300 MILLIONS D'EUROS
Exail Technologies annonce le succès de son offre d'obligations convertibles en actions, renforçant sa flexibilité financière pour refinancer l'acquisition d'iXblue -
COMMUNIQUÉ DE PRESSE
Correction of a Material Error Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital
OSE Immunotherapeutics corrects material error in total number of shares and voting rights, refutes accusations, and provides clarity on shareholder agreements and proxy advisory recommendations -
